Xu et al.77 assessed the regulatory network of LINC00152 in pan-cancer through bioinformatics analysis and found that the TFs FOS, ZEB1, and MAX bind to the SE region potentially upstream of the LINC00152 promoter, and knocking out LINC00152 inhibits the invasion and metastasis of the breast cancer cell line MDA-MB-231. Here, CYTOR is linked to breast carcinoma.